Oxygen dressing shows promise for healing diabetic foot wounds
NCT ID NCT07368816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special oxygen-enriched oil-based dressing on diabetic foot ulcers that form after surgery. Forty adults with diabetes took part and were randomly assigned to get either the new dressing or standard wound care. The main goal was to see if the ulcer healed completely within 16 weeks. The study was small and designed to gather early information for future larger trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- oxygen-enriched oil-based wound dressing
- What this could lead to
- If it works, this could offer a new, simple way to help heal diabetic foot ulcers after surgery.
- What could go wrong
- This is a very small pilot study with only 40 people. The results are preliminary and need to be confirmed in much larger trials. It may not work better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults (≥18 years) with diabetes mellitus * Presence of a post-surgical diabetic foot ulcer * Eligibility for topical wound treatment * Ability to provide written informed consent Exclusion Criteria: * Active malignancy * Severe systemic infection or sepsis * Known hypersensitivity to components of the wound dressing * Inability to comply with study procedures or follow-up * Participation in another interventional clinical study during the same period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic foot are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diabetology and Metabolism Unit, San Donato Hospital Arezzo, Local Health Authority South-East Tuscany, iTaly
Arezzo, AR, 52100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise without foot pressure: a new path for diabetic ulcer patients?
- 3D-Printed dental guide aims to boost precision in Root-End surgery
- Sound waves and nanoparticles join forces to heal diabetic foot wounds
- Smartphone app could let diabetic foot ulcer patients skip clinic visits for wound checks
- Placenta power: could donor cells heal diabetic foot wounds?
- Pig liver scaffold may speed healing of stubborn diabetic wounds